StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-0.08%)

Close on Nov 18, 2026Market cap $383.32KP/E –Yield –

VivoSim Labs price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

VivoSim Labs's price to sales ratio was 4.4× on Nov 11, 2026, against 41.7× a year earlier. Over the last 5 years it ranged from 4.4× to 288.9×, with a median of 27.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.4×−29.3
2025Dec 31, 202533.7×−34.9
2024Dec 31, 202468.6×+42.3
2023Dec 29, 202326.3×+18.5
2022Dec 30, 20227.8×−281.2
2021Jan 29, 2021288.9×+11.1
2020Dec 31, 2020277.9×+263.9
2019Dec 31, 201914.0×−14.4
2018Dec 31, 201828.4×−4.8
2017Dec 29, 201733.3×−67.9
2016Dec 30, 2016101.1×−122.3
2015Dec 31, 2015223.4×−263.6
2014Dec 31, 2014487.0×+52.8
2013Nov 29, 2013434.3×+374.0
2012Dec 31, 201260.2×–

More VivoSim Labs figures

See a number that looks wrong?